FY2025 · ended Dec 31, 2025 · Revenue $8.97M, +4.0% YoY · Filed Mar 31, 2026
Milestone Scientific Inc. (MLSS) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $9.0 million and a net loss of $5.7 million. Free cash flow was -$2.9 million. As of Jun 30, 2026 it held $2.1 million in cash and investments and $184,929 in total debt.
Revenue (TTM)
$9.42M
+3.7% vs year-ago TTM
Net income
$-5.72M
-21.4% vs prior year
Operating cash flow (TTM)
$-642,639
+87.8% vs year-ago TTM
Free cash flow
$-2.93M
+51.5% vs prior year
EPS
$-0.07
+30.0% vs prior year
Dividend per share
None
Shares outstanding
80.45M
+2.6% vs prior year
Net cash
$1.88M
as of Jun 30, 2026
Operating margin
-43.6%
FY 2026
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- MLSS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Livingston, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 855683
- Former names
- MILESTONE SCIENTIFIC INC/NJ (until Dec 17, 2009); U S OPPORTUNITY SEARCH INC (until Mar 14, 1997)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $9.0M | $8.6M | $9.8M | $8.8M | $10.3M |
| Operating income | -$5.7M | -$6.8M | -$7.1M | -$8.8M | -$7.4M |
| Net income | -$5.7M | -$4.7M | -$6.9M | -$8.7M | -$6.8M |
| Diluted EPS | -$0.07 | — | — | — | -$0.10 |
| Operating cash flow | -$2.9M | -$2.9M | -$5.3M | -$6.0M | -$4.0M |
| Free cash flow | -$2.9M | — | — | -$6.0M | -$4.0M |
| Total assets | $7.8M | $9.8M | $11.4M | $13.7M | $19.8M |
| Total liabilities | $5.0M | $4.0M | $3.4M | $3.7M | $3.6M |
| Stockholders' equity | $2.8M | $5.8M | $8.0M | $10.2M | $16.4M |
| Cash and investments | $1.1M | $3.3M | $6.0M | $17.4M | $29.6M |
| Total debt | $219,043 | $349,054 | $395,978 | $497,043 | $586,588 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 31, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Other events
|
Jul 29, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Jun 25, 2026 | Apr 30, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Auditor change
|
May 6, 2026 | Apr 30, 2026 |
All 810 Milestone Scientific Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.